FS is a relatively newly defined rare and devastating neurodevelopmental disorder, and currently, over 1,000 patients have been identified (according to the FOXG1 Research Foundation), with numbers steadily increasing in recent years due to advancements in genetic testing. The gene discussed is FOXG1; the disease is Feingold syndrome.